Replies to post #201784 on Biotech Values

[xavierprivas]

Agree with you on all the points. If AUPH result is not good enough
in August, then the stock will be 0 as they have no money. It is
not going to be down -60% or -70%.
IMO, new management have not raised money because they have no choice
but to wait for P2b result to get some decent term
as biotech financing is quite difficult lately (companies have
to settle for low end share price for IPO if they could even
get the opportunity for IPO, private placement to raise
money, etc.).
That said, quite a few think the odds of success are pretty good.
Just don't bet the farm on it.